Clinical Trials

Studies Currently Seeking Participants:

Cutaneous T-Cell Lymphoma

• H6Q-MC-JCCB: A Phase 2, Open-Label, Multicenter Study of Single-Agent Enzastaurin in Patients with Relapsed Cutaneous T-Cell Lymphoma (Dr. Alain Rook)


• The University Of Pennsylvania Department Of Dermatology is currently enrolling men and women over the age of 18 who have been diagnosed with CTCL, including mycosis fungoides and /or Sezary syndrome.

Chronic Plaque Psoriasis

• A PHASE 2B, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED TRIAL EVALUATING THE EFFICACY AND SAFETY OF DOSE REGIMENS WITH ORAL CP-690,550 IN THE TREATMENT OF SUBJECTS WITH CHRONIC PLAQUE PSORIASIS (Study Number A3921047) (Dr. Joel Gelfand)


• A randomized, double-blind, placebo controlled, multicenter regimen finding study of subcutaneously administered AIN457, assessing Psoriasis Area and Severity Index (PASI) response in patients with moderate to severe chronic plaque-type psoriasis



Moderate to Severe Chronic Plaque Scalp and Body Psoriasis

• This study will test the ability of etanercept to improve scalp symptoms (Dr. Joel Gelfand)

Advanced Basal Cell Carcinoma

• This is a pivotal phase II, multicenter, single-arm, two-cohort trial evaluating the efficacy and safety of GDC-0449 in patients with advanced basal cell carcinoma.



Hidradenitits Suppurativa

• A Phase 2 Multicenter Study of the Safety and Efficacy of Adalimumab in Subjects with Moderate to Severe Chronic Hidradenitits Suppurativa.



Hair Growth Prevention

• A randomized, placebo-controlled clinical trial to study the safety and efficacy of a topical medication for the prevention of hair growth.